204 results on '"Gomperts, Stephen N."'
Search Results
2. Optogenetic targeting of astrocytes restores slow brain rhythm function and slows Alzheimer’s disease pathology
3. Fluid and Tissue Biomarkers of Lewy Body Dementia: Report of an LBDA Symposium
4. Research criteria for the diagnosis of prodromal dementia with Lewy bodies
5. Preclinical and randomized clinical evaluation of the p38α kinase inhibitor neflamapimod for basal forebrain cholinergic degeneration
6. Disruption of hippocampal neuronal circuit function depends upon behavioral state in the APP/PS1 mouse model of Alzheimer’s disease
7. Development of a New Positron Emission Tomography Imaging Radioligand Targeting RIPK1 in the Brain and Characterization in Alzheimer's Disease.
8. Cellular resolution contributions to ictal population signals.
9. 18F‐flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter study
10. 18 F-flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter study.
11. Lewy body dementia: Overcoming barriers and identifying solutions
12. Clearing the Smoke: What Protects Smokers from Parkinson's Disease?
13. Serum NFL levels predict progression of motor impairment and reduction in putamen dopamine transporter binding ratios in de novo Parkinson's disease: An 8-year longitudinal study
14. Diagnosis and management of dementia with Lewy bodies
15. Differential Vulnerability of Hippocampal Subfields to Amyloid and TauDeposition in the Lewy Body Diseases.
16. Sleep functional connectivity, hyperexcitability, and cognition in Alzheimer's disease.
17. Association of Plasma Phosphorylated Tau With the Response to Neflamapimod Treatment in Patients With Dementia With Lewy Bodies
18. EEG Entropy in REM Sleep as a Physiologic Biomarker in Early Clinical Stages of Alzheimer’s Disease
19. Optogenetic Targeting of Astrocytes Restores Slow Brain Rhythm Function and Slows Alzheimer’s Disease Pathology
20. β-Glucocerebrosidase activity in GBA-linked Parkinson disease: The type of mutation matters
21. Activity Differentially Regulates the Surface Expression of Synaptic AMPA and NMDA Glutamate Receptors
22. Neuropathologic correlates of amyloid and dopamine transporter imaging in Lewy body disease
23. Frequency-dependent exacerbation of Alzheimer’s disease neuropathophysiology
24. Cellular contributions to ictal population signals
25. Pathological correlations of [F‐18]‐AV‐1451 imaging in non‐alzheimer tauopathies
26. Towards a phenome-wide view of Parkinson’s disease
27. Fluid and Tissue Biomarkers of Lewy Body Dementia: Report of an LBDA Symposium
28. Imaging the Role of Amyloid in PD Dementia and Dementia with Lewy Bodies
29. Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue
30. Fluid and Tissue Biomarkers of Lewy Body Dementia: Report of an LBDA Symposium
31. 18F-AV-1451 positron emission tomography in neuropathological substrates of corticobasal syndrome
32. Reply: Beyond the Limits of Detection: Failure of PiB Imaging to Capture True Aβ Burden
33. Brain amyloid and cognition in Lewy body diseases
34. Associations of Lower Caffeine Intake and Plasma Urate Levels with Idiopathic Parkinson’s Disease in the Harvard Biomarkers Study
35. Topography of cortical thinning in the Lewy body diseases
36. Clustering membrane proteins: it's all coming together with the PSD-95/SAP90 protein family
37. Cholinergic modulation of hippocampal calcium activity across the sleep-wake cycle
38. 18F-flortaucipir tau PET distinguishes established progressive supranuclear palsy from controls and Parkinson’s disease: A multicenter study
39. Author response: Cholinergic modulation of hippocampal calcium activity across the sleep-wake cycle
40. 18F-AV-1451 positron emission tomography in neuropathological substrates of corticobasal syndrome.
41. Prediction of cognition in Parkinson's disease with a clinical–genetic score: a longitudinal analysis of nine cohorts
42. β-Glucocerebrosidase activity in -linked Parkinson disease: The type of mutation matters.
43. Lessons learned about [F-18]-AV-1451 off-target binding from an autopsy-confirmed Parkinson’s case
44. Association of In Vivo [18F]AV-1451 Tau PET Imaging Results With Cortical Atrophy and Symptoms in Typical and Atypical Alzheimer Disease
45. Tau Positron Emission Tomographic Imaging in the Lewy Body Diseases
46. k dependence of Brillouin halfwidths.
47. Lewy Body Dementias
48. PET Radioligands Reveal the Basis of Dementia in Parkinson's Disease and Dementia with Lewy Bodies
49. VTA neurons coordinate with the hippocampal reactivation of spatial experience
50. 18 F-flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.